Global Neuroprosthetics Market Research and Forecast 2018-2023

Global Neuroprosthetics Industry Research Report

Orion market Research | OMR Global

Global Neuroprosthetics Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Rising prevalence of neural diseases is the major driver for the growth of neuroprosthetics market.”

— OMR Analyst

INDORE, INDIA, August 17, 2018 /EINPresswire.com/ — According to OMR analysis, the global neuroprosthetics market is expected to grow at a significant rate during (2018-2023). The global neuroprosthetics market has been showing significant growth due to increasing prevalence of neural diseases and rising inclination towards spinal cord injury treatment. The global neuroprosthetics market is segmented on the basis type, treatment technique, application and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market share analysis, competitive landscape, company profiling, market segmentation, geographical analysis, analyst insights.

Full report of global neuroprosthetics market is available at: https://www.omrglobal.com/industry-reports/neuroprosthetics-market/

“The global neuroprosthetics market on the basis of treatment technique is bifurcated as deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS) and spinal cord stimulation (SCS). DBS as a treatment has been approved by the FDA in 1997 for essential tremor and Parkinson's disease; in 2003 for dystonia; and for OCD in 2009. DBS system is being used in research studies for the treatment of chronic pain, Post-Traumatic Stress Disorder (PTSD). It has also been used for the treatment of various affective disorders such as major depression. DBS is a neurosurgical process that involves implantation of a medical device, neurostimulator or sometimes called brain pacemaker. This device sends electrical impulses to specific targets in the brain through implanted electrodes for treating the movement and neuropsychiatric disorders.”

The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is considered to be dominating market. The market is expected to grow at a stable CAGR. North American market is driven by high prevalence of spinal cord injuries, ability of people to afford the expensive treatment and research and development in artificial senses. Asia Pacific market is expected to have the highest CAGR amongst all regions for the forecast period of 2018-2023. APAC market is driven by increasing disposable income and improved healthcare facilities in the Asian countries.

The report covers:
· Comprehensive research methodology of Neuroprosthetics Market
· This report also includes detailed and extensive market overview with key analyst insights.
· An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
· Analysis of regional regulations and other government policies impacting the Neuroprosthetics Market
· Insights about market determinants which are stimulating the Neuroprosthetics Market
· Detailed and extensive market segments with regional distribution of forecasted revenues.
· Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/medical-devices/

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Global Neuroprosthetics Market Report


Source: EIN Presswire

Global Minimally Invasive Surgical Instruments Market Research and Forecast 2018-2023

Minimally Invasive Surgical Instruments Market

Global Industry Research By OMR

Global Minimally Invasive Surgical Instruments Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Rising prevalence of lifestyle-oriented diseases & technological innovations is fuelling minimally invasive surgical instruments market.”

— OMR Analyst

INDORE, INDIA, August 17, 2018 /EINPresswire.com/ — According to OMR analysis the global minimally invasive surgical instruments market is growing significantly during the forecast period 2018-2023. The global minimally invasive surgical instruments market has been segmented on the basis of product, technology and applications. The report provides detailed & insightful chapters which includes market overview, key findings, strategic recommendations, market estimations, device regulations, market determinants, key company analysis, market insights, company profiling, market segmentation, and geographical analysis.

Increasing prevalence of lifestyle oriented diseases such as CVD is driving the demand for minimally invasive surgical instruments market. According to WHO, CVD is the major cause of death globally and more people lost their lives due to CVD than any other cause. CVD has accounted around 17.7 million deaths in 2015. It represents 31% of all global deaths. Among these deaths, 7.4 million were occurred due to heart disease and 6.7 million due to stroke. More than three quarters of CVD deaths witnessed in low and middle income countries. Such prevalence of CVD leads the demand for minimally invasive surgical instruments for the treatment of patients with CVD. The advantage of minimally invasive cardiac surgery is extensive than the open-heart surgery. Open heart surgery requires 6-8 incision in the chest and might be needed temporary placement of a pacemaker to regulate patient’s heartbeat.

Full report of Global Minimally Invasive Surgical Instruments Market is available at: https://www.omrglobal.com/industry-reports/minimally-invasive-surgical-instruments-market/

However, the minimally invasive cardiac surgery can be performed using robotic and involves one or more tiny incisions between ribs. Thereafter, surgical instruments coupled with small camera are placed through the incision. Then, the surgical tools are linked to the arms of robotics that is controlled by the surgeon with a computerized device. The instruments used in minimally invasive cardiac surgery include retractors, forceps, cutter instruments, stents and sutures. Additionally, minimally invasive cardiac surgery methods are used in atrial septal defect closure, aortic valve replacement, mitral valve repair and maze procedures to treat atrial fibrillation. There are several benefits associated with minimally invasive cardiac surgery as smaller incisions are involved in it. Moreover, it includes shorter hospital stays (generally 2-5 days), minimal risk of bleeding and infection, less scarring and pain and shorter recovery time.

The global minimally invasive surgical instruments market is segmented into product, technology and applications. Based on technology, robotic-assisted methods are gaining significant popularity and technological innovations have been observed which is increasing the effectiveness of this technology. Robot-assisted methods are used in several specialties, including head and neck surgery, urology, gynecologic oncology, cardiothoracic and gastrointestinal. For example, In Dec 2016, Cambridge consultants developed Axsis robot to overcome challenges of current surgical robots, including the inability to act with extremely fragile and detailed tissues and large size of the robots. Like da Vinci surgical systems, Axsis doesn’t use rigid and long instruments, however, rely on flexible components results in the smaller size of the robot. Axsis is designed to perform cataract surgery. It has flexible, tiny and worm-like arms and controlled with a joystick that offers tactile feedback. Additionally, it has an internal algorithm autopilot that keeps the surgeons who are guiding it to not make dumb mistakes. The system assimilates with real-time 3D imaging that provides an advanced level of robotic assistance. Posterior Capsule (PC) tears are the most common serious complications in the UK. Axsis can reduce complications rates and develop patient outcomes.

The report covers:
Comprehensive research methodology of Global MIS Instruments Market.
This report also includes detailed and extensive market overview with Analyst insights & key market trends.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global MIS Instruments Market.
Insights about market determinants which are stimulating the Global MIS Instruments Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/medical-devices/

About orion market research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Global Minimally Invasive Surgical Instruments Market Research Report


Source: EIN Presswire

Luxury Tour Provider Announces Private Scuba Diving Onboard Exclusive Catamaran Yacht

Luxury yacht charter in Cabo San Lucas

Scuba diving in Cabo San Lucas

Have a Magical Experience Onboard a Luxury Yacht and Explore the Depths of the Sea of Cortez with Private Scuba Diving Tours!

Life is a journey with problems to solve, lessons to learn, but most of all, Experiences to enjoy”

— unknown

CABO SAN LUCAS, BAJA CALIFORNIA SUR, MEXICO, August 16, 2018 /EINPresswire.com/ — FOR IMMEDIATE RELEASE: Operator of the highest rated luxury cruises is now offering voyages aboard luxury catamaran yachts along with a private luxury scuba diving experience. The luxury scuba diving holiday provider has announced they are now also offering private luxury scuba diving onboard a luxury catamaran yacht with state-of-the-art facilities and impeccable services.
At a recent launch event, the spokesperson for the company said, CABO YACHT WORLD is proud to announce that we have recently added a new yacht to our scuba diving excursions. We are extremely excited to have included a luxury Catamaran yacht ARISE to our fleet specially because we have a dive master on board that has been certified even for handicapped guests, and the addition of the new luxury Catamaran yacht is sure to add to the amazing experience.”
The Catamaran is a multi-hulled watercraft that features state-of-the-art facilities such as, two parallel hulls. That Catamaran is a geometry-stabilized craft, and derives its stability from its extra wide beam, rather than a monohull sailboat which has a ballasted keel. Thus, it offers complete comfort while sailing and scuba diving.
On answering a question, the spokesperson stated, “We are very happy with the inclusion of the new catamaran yacht to our scuba diving tour. The Catamaran offers the best in comfort and luxury, with spacious cabins, en-suite facilities and a sprawling deck along with salon areas.You can rest assured that our 64 ft. Catamarans have all amenities and equipment one would look for uninterrupted dives, making it the perfect vessel for exploring remote areas where underwater treasures are waiting to be explored in the sea of Cortez.”
The MY 64ft (19.51m) Lagoon Catamaran Yacht will be sailing to the relatively untouched Sea of Cortez, also known as the ‘Gulf of California’ which is considered to be one of the hot spots for biodiversity and marine life, along with a flourishing coral reef that’s just waiting to be explored. The sea is wedged between Baja California and the mainland Mexico with a sheltered and narrow outline, which results to mostly calm waters, making it an ideal spot for the best scuba diving experience possible.
He concluded by saying, “Our luxury scuba diving tour onboard a luxury catamaran yacht is perfect for people who love the sea. the Sea of Cortez is an amazing place to visit. The warm waters are relatively calm, with high mountains in a distance rise from the bluish-green sea and upwards to the blue sky. It is the perfect place to spend a full day with friends or family. Once below the water, you are freed from gravity, and experience absolute freedom. Guests on our luxury scuba diving tours will get to spot up to 900 different fish species. Gently touch them, sit on the ocean’s floor, or play with the sand, and feel like a true National Geographic explorer of the deep sea. The boat ride to and from the dive site is also a sight to behold, not only because of the amazing natural beauty of the surroundings but because Grey whales and Humpback are often spotted en route, which makes the experience magical.In short, it’s a great body of water to explore, and we’d love it if you would join us for this unforgettable adventure.”
Private luxury scuba diving onboard a luxury Catamaran yacht along with other tours are available for pre-booking by calling [01 52 624 168 9544] or emailing us at [caboyachtworld@gmail.com]. Guests of our Luxury Catamaran Yacht and diving experience can also arrange for private tours and excursions that are customized according to their needs and travel budgets.

About Us:
Cabo Yacht World operates award-winning luxury Catamaran yachts and cruising luxury yachts, which provide exceptional cruising experiences to its guests. All tours can be tailored to specific needs of tourists to provide an unparalleled experience at the most enchanting destinations. The tour company is committed to delivering a high level of quality with their private and group tour packages.
Contact Information
Cabo Yacht World
Boulevard marina s/n lte E1B Col. Centro Cabo San Lucas BCS 23450
01 52 624 157 1136
caboyachtworld@gmail.com
https://www.caboyachtworld.com/63-foot-lagoon-catamaran/

Arturo Chacon
Cabo Yacht World
6241689544
email us here

64 foot Lagoon luxury yacht charter in Cabo San Lucas


Source: EIN Presswire

The Boy Scouts Dive in to a Different Dimension With The L. Ron Hubbard East Coast Theatre

L. Ron Hubbard East Coast Theatre actors perform a final rehearsal of the classic Science Fiction story “The Dangerous Dimension” at the Clearwater Community Volunteers Center in downtown Clearwater. In the audience were the Boy Scouts of Troop 313

L. Ron Hubbard's East Coast Golden Age Theatre opens rehearsal to the public for the first time at the Clearwater Community Volunteers Center in downtown

CLEARWATER, FLORIDA, USA, August 16, 2018 /EINPresswire.com/ — On Tuesday August 14, the Clearwater Community Volunteers Center, opened and supported by the Church of Scientology Flag Service Organization, hosted the L. Ron Hubbard East Coast Theatre in their final rehearsals of their upcoming presentation of L. Ron Hubbard’s pulp fiction story The Dangerous Dimension. The rehearsal served as an exclusive behind the scenes preview for Boy Scout Troop 313 before the Theater’s live performance on August 18 in the Scientology Information Center, located on the corner of Cleveland Street and Fort Harrison Ave.

This is the first time the Theatre allowed a group to see their rehearsal. The Boy Scouts saw how the theater polishes each final performance using costumes and sound effects.

“These actors practice every week to create a stellar performance that will bring people in the community together,” said Michael Soltero, Manager of the Center. “By opening their rehearsals to the Boy Scouts they accomplish what the Center was established for: bringing different community groups together. They’re doing as humanitarian L. Ron Hubbard wrote, ‘A community that pulls together can make a better society for all.”

The Dangerous Dimension by L. Ron Hubbard is based on Dr. Henry Mudge, who discovers the mathematical formula “Equation C”, which outlines a negative dimension. Using this equation, Dr. Mudge is instantly transported to any location in the solar system by simply thinking of it.

For more information about the Clearwater Community Volunteers Center or to attend an upcoming event, please call Michael Soltero at (727) 316-5309 or email ccvcenter@ccvfl.org.

About the Clearwater Community Volunteers:

The Clearwater Community Volunteers (CCV) have over 25 years of community service under their belt with over 150,000 families and children helped since their founding in 1992. CCV stays true to their reputation of helping others with their new center, located on the corner of Fort Harrison Ave. and Drew St. in downtown Clearwater, which facilitates the growth of non-profits by serving as a free event venue & meeting space. CCV and the CCV Center are sponsored by the Church of Scientology Flag Service Organization.

Pat Harney
Church of Scientology Flag Service Organization
727-467-6860
email us here


Source: EIN Presswire

Global Pharmacy Benefit Management Market (PBM) 2018 Analysis and Forecast to 2023 Research Report

MarketResearchNest.com adds “Global Pharmacy Benefit Management (PBM) Market 2018 by Manufacturers Regions Type and Application to 2023” report to its database.

PUNE, INDIA, August 16, 2018 /EINPresswire.com/ — MarketResearchNest.com adds “Global Pharmacy Benefit Management (PBM) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” new reports to its research database. The report spread across 133 pages with tables and figures in it.

Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.

This report focuses on the Pharmacy Benefit Management (PBM) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pharmacy Benefit Management (PBM) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Order a purchase report copy of at https://www.marketresearchnest.com/report/purchase/403080 .

Market Segment by Manufacturers, this report covers
CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
BC/BS
Vidalink
Sea Rainbow
Cachet

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Inquire before Buying at https://www.marketresearchnest.com/report/enquirybuy/403080 .

Market Segment by Type, covers
commercial health plans
self-insured employer plans
Medicare Part D plans
Federal Employees Health Benefits Program
state government employee plans

Market Segment by Applications, can be divided into
Mail-order Pharmacy Services
Non-mail Pharmacy Services

There are 15 Chapters to deeply display the global Pharmacy Benefit Management (PBM) market.
Chapter 1, to describe Pharmacy Benefit Management (PBM) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pharmacy Benefit Management (PBM), with sales, revenue, and price of Pharmacy Benefit Management (PBM), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pharmacy Benefit Management (PBM), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pharmacy Benefit Management (PBM) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pharmacy Benefit Management (PBM) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Get a Report Details at https://www.marketresearchnest.com/Global-Pharmacy-Benefit-Management-PBM-Market-2018-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2023.html .

About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

Contact Us
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070 / +44-20-3290-4151

Mr Jeet
Market Research Nest
1-240-284-8070
email us here


Source: EIN Presswire

PetVivo Holdings, Inc. Moves Manufacturing Facility, Creates Research and Development Laboratory.

(All Press Releases Will Be Available for Viewing on Facebook or the Web at www.petvivo.com )

MINNEPOLIS, MINNESOTA, USA, August 16, 2018 /EINPresswire.com/ — PETVIVO HOLDINGS, INC. MOVES AND EXPANDS MANUFACTURING FACILITY. CREATES RESEARCH AND DEVELOPMENT LAB

(OTCMARKETS: PETV), PetVivo Holdings, Inc. (www.petvivo.com) an emerging biomedical device company, is pleased to announce the moving of its manufacturing facility and the creation of a research and development lab.

In an effort to expand manufacturing and create a research and development facility, Petvivo, Inc. moved from Elite Solutions in Rochester, Minnesota to the home of CytoMedical Design Group LLC (cmdg) in St. Paul, Minnesota. The location has far better access for Petvivo employees and eliminates the costs of hotels and mileage which the company has been absorbing sending and supporting staff from Minneapolis for weeks at a time to work in Rochester.

“We estimate that our cost of manufacturing will be reduced substantially. It is also time to address our plan to continue improving our product and initiate our research and development plans. Assistance for both manufacturing and research will be available from staff members of the cmdg group. Cmdg has additional clean rooms and square footage for our use “commented Wes Hayne, CEO of Petvivo Holdings, Inc.

The move was performed in one week, coordinated with three different moving companies. Each company specializing in specific equipment, with different degrees of sensitivity. The move is now complete, and production is expected to resume within the next three weeks. The new surroundings and extra space will help in building the efficiencies of the manufacturing process.

About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (OTCPINK: PETV) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets and pet therapeutics. PetVivo is leveraging investments made in the human medical device industry to commercialize therapeutics for pets in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.
PetVivo's strategy is to commercialize proprietary products from human medical device companies specifically for the companion animal market. The company’s product pipeline includes seventeen animal and human therapeutics. A portfolio of twenty patents protects the company’s products, production processes and biomaterials. PetVivo’s lead product, a veterinarian-administered joint injection for the treatment of osteoarthritis in dogs, is scheduled for launch later this year.
Forward-Looking commercial Statements:
The foregoing material may contain forward-looking statements. We caution that such statements may be subject to uncertainties and that actual results could differ materially from the forward-looking statements. Readers accordingly should not place undue reliance on these forward-looking statements, which do not reflect unknown or unanticipated events or circumstances occurring after the date of these forward-looking statements.

Wes Hayne
Petvivo Holdings Inc
962-405-6216
email us here


Source: EIN Presswire

The Astronot makes its Canadian Premiere at the Regina International Film Festival in Saskatchewan

Pennan Brae wote, scored, starred in and co-produced The Astronot.

Regina International Film Festival

The Astronot is a feature film drama set during the 1960’s space race, written, scored, starring and co-produced by Pennan Brae.

It's an honour to have The Astronot make its Canadian premiere at the RIFF. As a Canadian, it's great to take part in a domestic festival and what better place than the lovely city of Regina?”

— Pennan Brae

REGINA, SASKATCHEWAN, CANADA, August 15, 2018 /EINPresswire.com/ — The Astronot, currently on the film festival circuit, is excited to announce its official Canadian premiere at the Regina International Film Festival in Regina, Saskatchewan. The feature film is an Official Selection in the Feature Film category and will screen at the Cineplex Odeon South on Thursday, August 16 at 11:00 am – 12:15 pm. (The Regina International Film Festival runs from August 14 – 18th.) The film has already won dozens of awards worldwide.

The feature film is a drama set during the space race of the 1960’s, written, scored, starring and co-produced by Pennan Brae. 

The film follows Daniel McKovsky, a young man who lost both his parents at a young age and whose only solace is in his fascination with space travel and the cosmos beyond. One day at the age of 30, he meets outgoing postal worker, Sandy Allister. This new inclusion into his otherwise lonely existence forces Daniel to confront his darkest fears of loss and emptiness which shall lead him towards becoming, The Astronot.

The Astronot was filmed in rural Oregon, using local cast and crew, including director Tim Cash of Far From Earth Films. The Astronot has already won accolades at various international film festivals in the USA, UK & Europe including Best Actor (Pennan Brae), Score (Pennan Brae) and Trailer.



'It's an honour to have The Astronot make its Canadian premiere at the RIFF. As a Canadian, it's great to take part in a domestic film festival and what better place than the lovely capital city of Regina.”- Pennan Brae



Also a musician, Pennan Brae’s upcoming album (also called, The Astronot), features 11 songs which serve as the film’s soundtrack. The first single, “Walk With Me” was already released to radio in the UK, Canada & Europe and received airplay on over 200 stations. The album was recorded at Blue Light Studio in Vancouver with producer Kaj Falch-Nielsen, with additional sessions taking place in Los Angeles with composer/producer Eric Alexandrakis, renowned drummer Steve Ferrone and INXS bassist Garry Gary Beers. The second single, ‘Crashland’ is set for release to Canadian radio one week following the Regina festival.


To view the trailer, please visit: www.TheAstronot.com.

Amanda Alexandrakis
Film Marketeers
970.377.0313
email us here

The Astronot Official Trailer


Source: EIN Presswire

Hardman Batchelor Places Jim Ramsey as Vice President, Americas Sales For National Instruments Corporation

Picture of Jim Ramsey

Jim Ramsey

Logo for Hardman Batchelor International

Hardman Batchelor International, a global retained executive search firm, completes Vice President Americas Sales search for National Instruments Corporation.

Jim Ramsey was a clear choice among a list of top national candidates given his relevant experience and admired reputation as a strong sales leader, mentor and coach.”

— Edward Batchelor, Managing Partner

AUSTIN, TEXAS, USA, August 15, 2018 /EINPresswire.com/ — Following a national search, global retained search firm Hardman Batchelor International has placed executive Jim Ramsey as the new Vice President, Americas Sales of National Instruments Corporation (NASDAQ: NADI) effective immediately. Headquartered in Austin, National Instruments develops and manufactures software and hardware products that engineers and scientists use for test, control and embedded design applications. In 2017, the company sold products to more than 35,000 companies with revenues of more than $1.29 billion and global operations across 50 countries. The search was led by Managing Partner, Edward Batchelor, software & technology practice leader of HBI.

Jim Ramsey brings over 30 years’ experience in sales and sales strategy, joining NI two and a half years ago to spearhead the Americas Partner strategy and team. Prior to NI, Jim spent most of his career at Maxim Integrated where he drove design influence across a $1 billion business achieving double-digit growth. In this Vice President of Sales for the Americas, he will have overall responsibility for the development and execution of the sales plan (representing 40% of the revenue of NI) with responsibility to increase the Company’s market share as well as capture new customers. He will also have dotted line responsibility for the regional marketing and operations functions partnered with the Americas region which are now centralized globally.

“Jim Ramsey was a clear choice among a list of top national candidates given his relevant experience and admired reputation as a strong sales leader, mentor and coach.” Mr. Batchelor said.

Hardman Batchelor also recently placed Paul Horton as Vice President, Global Operations at National Instruments Corporation. He brought a wealth of experience in Global Finance, Information Solutions and Sales Operations across General Motors, EDS, Hewlett Packard Enterprises Services and DXC Technology (CSC and HP Enterprises Merger). He most recently served as the Vice President of Global Sales Operations at DXC where he led project teams that designed the new company’s sales organization, processes and compensation.

About Hardman Batchelor International

Founded by former “Big Five Firm” Partner Edward Batchelor, Hardman Batchelor International is a groundbreaking global firm specializing in recruiting and assessing world-class Board Directors, CEOs and C-Level executives with a particular focus on confidential mandates and cultivating the underserved “Middle America” marketplace. The firm offers retained executive and board level search; reference checking; candidate benchmarking; and management assessment. It has been recognized as a 2018 Hunt Scanlon Global Talent Leader signifying quality, exceptional service and distinguished leadership in executive recruiting.

Edward Batchelor
Hardman Batchelor International
+1 512 761 3268
email us here


Source: EIN Presswire

Cutting-edge Research to be Presented at The Pacific Mesothelioma Center's Symposium on Mesothelioma at UCLA

On September 29th global experts will convene at The Luskin Conference Center at UCLA for the 8th International Symposium on Malignant Pleural Mesothelioma.

LOS ANGELES, CA, USA, August 15, 2018 /EINPresswire.com/ — On September 29th global experts on malignant pleural mesothelioma will again convene at the Meyer & Renee Luskin Conference Center at UCLA for the 8th Annual International Symposium on Malignant Pleural Mesothelioma (MPM), a rare form of cancer that results from exposure to asbestos and commonly affects the lining of the chest– the pleura. The event is jointly hosted by UCLA and the Pacific Mesothelioma Center (PMC).

The Symposium is geared towards physicians and offers continuing medical education (CME) credit. It will also provide up-to-date information on mesothelioma for medical students, nurses and other healthcare professionals, as well as mesothelioma patients, their families, and other interested parties. Topics will cover: Perioperative Immunotherapy; Mesothelioma Clinical Trials; Novel MRI Assessment of Mesothelioma Tumor Volume; Toxicities and Outcomes Using Whole Pleural Intensity – Modulated Proton Therapy; Understanding the Immune Response to Radiotherapy in a Dual Tumor Model of Mesothelioma; Integrative Molecular Characterization of Mesothelioma: Cancer Genome Atlas Project; A Modified Measles Virus Against Mesothelioma; An Exhaled Breath Biopsy Earmarks Exclusive Screening for MPM; Mesothelioma Immunotherapy by Controlling T Cell-Mediated Immunity; Overcoming the Immunosuppressive Tumor Microenvironment of Murine Malignant Mesothelioma and more.

The Symposium will be led by Robert B. Cameron, MD, FACS, Director of the UCLA Mesothelioma Comprehensive Research Program and Professor of Thoracic Surgery at the David Geffen School of Medicine at UCLA. The roster of distinguished international faculty at the Symposium will include Kevin G. Blyth, MD, MBchB, FRCP, University of Glasgow; Nicolas Boisgerault, PhD, CRCINA Cancer Research Center, France; Lisa M. Coussens, PhD, Oregon Health and Science University, Portland; Mikihiro Kohno, MD, PhD, University of Toronto, Canada; Marc Ladanyi, MD, Memorial Sloan Kettering, New York; Kevin Lamote, PhD, University of Antwerp, Belgium; Charles B. Simone II, MD, University of Maryland Medical Center, Baltimore, Maryland; Wesley Wilson, PhD Candidate, University of Western Australia Perth, Australia, as well as local experts from UCLA.

"There is so much exciting science from around the world in terms of treatment for mesothelioma, with promising medical advances and new research” said Dr. Cameron. “This year we have changed the format to concentrate more on clinical and research sessions and have incredible speakers from all around the world”. The symposium gives an unrivaled opportunity for both the medically savvy and general public, including mesothelioma patients, to not only learn first-hand about groundbreaking discoveries but also to exchange ideas.

Early Bird tickets can be purchased before September 6th online at http://www.cme.ucla.edu/courses/.

The Pacific Heart, Lung & Blood Institute (PHLBI) is a 501(c)(3) non-profit medical research institute established in 2002. One of the divisions, The Pacific Mesothelioma Center (PMC) is focused on the treatment and prevention of malignant pleural mesothelioma (MPM). The exploration of innovative ideas forms the foundation of PMC’s unique research program and provides the promise of future treatment breakthroughs. PMC is dedicated to educating the public on asbestos-related diseases and informing them of their best treatment options. PMC also connects newly diagnosed patients with other patients that have been through treatment and provides assistance and emotional support.

Clare Cameron
The Pacific Mesothelioma Center
310-478-4678
email us here


Source: EIN Presswire

Marrone Bio Innovations Submits Novel Bioherbicide to the EPA for Regulatory Approval

Novel mode of action for resistant weeds such as palmer amaranth

Marrone Bio Innovations (NASDAQ:MBII)

We are excited about what we have seen so far in 014 development. We have more work to determine appropriate doses on key target weeds, water volume, adjuvans and further expansion of the spectrum.”

— Amit Vasavada, Senior Vice President of R&D and Chief Technology Officer

DAVIS, CA, USA, August 14, 2018 /EINPresswire.com/ — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, has submitted the registration package for its new bioherbicide, MBI-014, to the United States Environmental Protection Agency (EPA).

Weeds are a major source of yield losses for most cropping systems. According to various market research reports, herbicides account for 40% of the $50 billion global pesticide market. Of the approximately $7.2 billion chemical pesticides sold in the U.S. each year, nearly $4 billion are chemical herbicides.

Grower surveys repeatedly show that weed control is the number one cost of organic food production since chemical herbicides are not allowed. In organic growing systems, herbicide options are extremely limited, consisting almost entirely of non-selective soaps and acids that typically require repeat applications, lack residual activity, only affect plant areas into which they come in direct contact, and sometimes cost more than hand weeding. According to the Organic Trade Association, organic food sales reached $45 billion in the U.S. and is the fastest growing segment of food, growing an average of 9.1% annually since 2008.

MBI-014 is a water dispersible microbial herbicide made from a new species of heat-killed bacteria, Burkholderia rinojensis (strain A396). This new herbicide has a novel mode of action per research conducted at the USDA Agricultural Research Service. While additional development work and field trials need to be conducted, MBI-014 could prove to be a valuable new tool for weed control when used in conjunction with other herbicides in a grower’s integrated pest management (IPM) program.

MBI-014 demonstrates post-emergent herbicidal activity across a range of weeds in laboratory and field tests. It shows evidence of uptake and moderate movement through different plant tissues. MBI-014 is most effective on some of the most serious weeds, some of which have developed resistance to multiple herbicide classes, such as palmer amaranth, waterhemp and others in the pigweed family (Amaranthacae).

“We are excited about what we have seen so far in the development of MBI-014,” said Amit Vasavada, Senior Vice President of R&D and Chief Technology Officer at Marrone Bio Innovations. “We do have more work to do in order to determine such things as appropriate doses on key target weeds, water volume required, adjuvant package needed and further expansion of the spectrum of targeted weeds.”

Sources of cited information: Phillips McDougall Agribusiness Intelligence, Weed Science Society of America, University of Missouri, Organic Trade Association, Organic Farming Research Foundation, USDA.

Pam Marrone
Marrone Bio Innovations
5307502800
email us here


Source: EIN Presswire